Cannabis Bioscience International Holdings (CBIH) Total Non-Current Liabilities (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $249500.0 for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $249500.0, down 7.73% year-over-year; the trailing twelve-month figure through Feb 2026 was $249500.0 (down 7.73% YoY), and the FY2025 annual result was $249500.0, down 1.87% from the prior year.
• Total Non-Current Liabilities came in at $249500.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $249500.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $326937.0 in Q4 2024 to a low of $249500.0 in Q2 2023.
• The 4-year median for Total Non-Current Liabilities is $249500.0 (2023), against an average of $263731.1.
• Across the five-year window, Total Non-Current Liabilities grew 15.35% in 2024 and declined 23.69% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Total Non-Current Liabilities stood at $283420.0 in 2023, then advanced by 15.35% to $326937.0 in 2024, then slipped by 23.69% to $249500.0 in 2025, then changed by 0.0% to $249500.0 in 2026.
• The last three Total Non-Current Liabilities figures came in at $249500.0 (Q1 2026), $249500.0 (Q4 2025), and $249500.0 (Q3 2025), per Business Quant data.